- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed and/or Relapsed-refractory Multiple Myeloma in Ireland
Total 1307 results
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedDiabetic Peripheral NeuropathyUnited States, Czechia, Sweden, South Africa
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Argentina, Canada, Peru, Australia, Latvia, Costa Rica, Russian Federation, New Zealand, Colombia, Mexico, Czech Republic, Ecuador
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedNeutropenia | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Ovarian Carcinosarcoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Infectious DisorderUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Germany, Estonia, Russian Federation, South Africa, India, Ukraine, Mexico, Greece, New Zealand, Poland, Czechia, Lithuania, Romania, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMedulloblastoma | Nevoid Basal Cell Carcinoma Syndrome | Desmoplastic/Nodular Medulloblastoma | Medulloblastoma With Extensive NodularityUnited States, Canada, Puerto Rico, Australia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, India, Israel, Italy, Mexico, Puerto Rico, Russian Federation, Spain, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Taiwan, Finland, Norway, Serbia, South Africa, Turkey, Canada, France, Germany, Korea, Republic of and more
-
Incyte CorporationTerminatedPancreatic CancerUnited States, France, Colombia, Israel, Portugal, Netherlands, Chile, Puerto Rico, Sweden, Austria, Denmark, Mexico, Ireland, Switzerland
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czechia, France, Hungary, Slovakia, United Kingdom
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Canada, Belgium, Denmark, Spain, Ireland, Netherlands, United Kingdom, Hungary, Italy, France, Austria, Czechia, Norway, Finland, Sweden
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedDiabetes MellitusChina, United States, Canada, Mexico, Russian Federation, Croatia, United Kingdom, Argentina, Australia, India, South Africa, Greece, Ukraine, Romania, Italy, Hong Kong, Former Serbia and Montenegro, Brazil
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, China, Taiwan, Canada, Switzerland, Japan, Brazil, Russian Federation, Hungary, Greece, France, Israel, Sweden, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Israel, Russian Federation, Slovakia, Canada, Serbia, United Kingdom, Puerto Rico
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Sweden, United States, Mexico, South Africa, Russian Federation, France, Spain, Switzerland, Canada, Finland, New Zealand, Korea, Republic of, Thailand, Israel, Germany, Peru, Australia, Denmark, Italy, Ukraine, Greece, Puerto Rico, Guatemal... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2India, United States, Thailand, Japan, Germany, Turkey, Hungary, Malaysia, Poland, South Africa, Czechia, Italy, France, Slovenia
-
Millendo Therapeutics US, Inc.Covance; Medpace, Inc.Terminated
-
Tesaro, Inc.Gynecologic Oncology GroupTerminated
-
PfizerTerminatedDiabetes MellitusCanada, United States, Brazil, Puerto Rico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Peru, Israel, Australia, United Kingdom, Korea, Republic of, Spain, Philippines
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, Japan, China, India, Mexico, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Canada, Poland, Denmark, Spain, Croatia, Sweden, Greece, Belgium, France, New Zealand, South Africa, Israel, Brazil, Ireland, Netherlands, Lithuania, Slovakia
-
Eli Lilly and CompanyCompletedObesity | Overweight | Type 2 DiabetesUnited States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
-
Royal College of Obstetricians and GynecologistsCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Chile, Argentina, Brazil, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Canada, France, Poland, Germany, Israel, India, Ukraine, Korea, Republic of, Malaysia, Netherlands, New Zealand, Singapore, Brazil, Austria, Denmark, Belgium
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Belgium, Canada, China, Croatia, Czech Republic, Finland, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Poland, R... and more
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Daiichi Sankyo, Inc.Completed
-
AstraZenecaCompletedDiabetesFrance, Spain, United Kingdom, Germany, Greece, Italy, Netherlands, Ireland
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
Mylan Inc.Mylan GmbHCompletedType 2 DiabetesUnited States, Jordan, Korea, Republic of, Slovakia, South Africa, Taiwan
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyTerminatedPancreatic Adenocarcinoma | Stage III Pancreatic CancerUnited States
-
NewLink Genetics CorporationCompleted
-
AstraZenecaTerminatedType 2 DiabetesUnited States, Brazil, Czech Republic, France, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Spain, United Kingdom, Vietnam, Germany, Philippines, Malaysia, Sweden, Estonia, Latvia, Lithuania, Finland, Norway and more
-
NHS Greater Glasgow and ClydeCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited Kingdom, Australia, New Zealand
-
TakedaCompletedDiabetic NeuropathiesUnited States, Canada
-
AbbVieCompletedPolycystic Ovary SyndromeUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedChronic Pain | Diabetic Peripheral Neuropathic Pain | Diabetic Peripheral NeuropathyUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Russian Federation, United States, Spain, Italy, Puerto Rico, Canada, Poland, Austria, Hungary, Israel, Greece, Taiwan, Argentina, Romania, Mexico, Slovakia
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedColorectal Cancer | Neurotoxicity | Neuropathy | Chemotherapeutic Agent ToxicityUnited States, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | AIDS-Related Opportunistic InfectionsUnited States, Puerto Rico, South Africa
-
Mannkind CorporationCompletedType 1 Diabetes | Type 2 DiabetesUnited States, Brazil, Canada, Russian Federation
-
PfizerTerminatedDiabetes Mellitus Type 2Spain, Canada, France, Greece, Portugal, Sweden, Turkey
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c LevelCzech Republic, Poland, Spain, Germany, Canada, Slovakia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, United Kingdom, Canada, Italy, Hungary, Spain, Sweden, Australia, Netherlands, France, Czechia, Finland, Germany, Greece, Ireland, Latvia, Mexico, New Zealand, Norway, Poland, Portugal, Romania, Russian Federation, South...
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Mexico, South Africa
-
Bristol-Myers SquibbCompletedMetabolics Diabetes NosUnited States, Spain, Argentina, Brazil, Germany, Mexico, Peru, Puerto Rico, Australia, Canada, Russian Federation, United Kingdom, France, Italy, Netherlands